The generic name of Minxilang is betahistine mesylate. Although there is no clear indication about how long the medication will be effective, clinically it is generally taken for 1 week will have some effect, the specific medication should follow the doctor’s instructions. Betahistine Mesylate has the ability to treat cerebral arteriosclerosis, inner ear vertigo, vertigo, cerebral ischemic disease caused by insufficient blood supply, tinnitus, nausea, pressure sores and vomiting and other conditions. It is prohibited for children, women during pregnancy and those who are allergic to the pharmaceutical composition of betahistine mesylate. Betahistine Mesylate is used with caution in diseases such as peptic ulcer, bronchial asthma and pheochromocytoma. Breastfeeding women need to stop breastfeeding when they need to take the drug. Adverse reactions such as nausea, headache, aggravation of peptic ulcer and palpitations may occur after taking Betahistine Mesylate. Those who suffer from the above conditions need to take Betahistine Mesylate under the guidance of a doctor, usually taking 1 week will have a certain effect, if there is no relief, you need to consult a doctor in time.